Angle ShareCast News (AGL)



ShareCast News for Angle (AGL)


Share Price: 56.50Bid: 56.00Ask: 57.00Change: -2.25 (-3.83%)Faller - Angle
Spread: 1.00Spread as %: 1.79%Open: 58.75High: 59.375Low: 56.50Yesterday’s Close: 58.75






Angle shares jump on cell harvesting update

Shares in Angle, a specialist medtech company, leapt 20 per cent on Monday after the group said it has extended the operational capability of its Parsortix non-invasive cancer diagnostic product by automating its cell harvesting function.
[13 May '13]

Angle initiates launch of cancer diagnostic product for market research

Angle, an AIM-listed specialist medtech company, has initiated the launch of its Parsortix non-invasive cancer diagnostic product for the research market.
[28 Feb '13]

Angle raises funds with placing

Angle, a specialist medtech company, has placed 4.53m new ordinary shares at 50p each, representing a discount of 17.4 per cent on the mid-price of 60.50p per share at close of business on Wednesday.
[31 Jan '13]

Angle jumps again after pay out

Medical technology firm Angle saw its shares jump for a second day in a row after it received cash due from the sale of its portfolio company Acoylte Biomedica.
[15 Jan '13]

Angle gains on breakthrough in cancer diagnostic technology

Angle advanced more than 90 per cent Monday after the medtech company announced a major breakthrough in its cancer diagnostic product Parsotix.
[14 Jan '13]

Sharp drop in Angle shares following business update

AIM-listed medtech company Angle revealed that Origio, a partner involved in the development of a technology patented as EmbryoSure, has decided to cease EmbryoSure studies in a business update on Monday.
[10 Dec '12]

Small caps round-up: Cyan, Aer Lingus, Mobile Tornado ...

Also covered by this round-up: ANGLE and Sareum Holdings.
[7 Jun '12]

Small caps round-up: Westminster Group, Angle, Asterand

Also includes: Coms, Motive Television
[30 Apr '12]




Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.